Key Details
Price
$2.85Annual ROE
-83.21%Beta
1.13Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Mar 01, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.
Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2024 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.
LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can joi.
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcadia Biosciences (RKDA) is using the sale of its GoodWheat brand to expand its wheat intellectual property.
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will be hosting a call for analysts and investors on May 22, 2024, after the market closes. The conference call, scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time), will focus on recent strategic transactions. Interested participants can join the call through an audio-only webcast.
FAQ
- What is the primary business of Arcadia Biosciences?
- What is the ticker symbol for Arcadia Biosciences?
- Does Arcadia Biosciences pay dividends?
- What sector is Arcadia Biosciences in?
- What industry is Arcadia Biosciences in?
- What country is Arcadia Biosciences based in?
- When did Arcadia Biosciences go public?
- Is Arcadia Biosciences in the S&P 500?
- Is Arcadia Biosciences in the NASDAQ 100?
- Is Arcadia Biosciences in the Dow Jones?
- When was Arcadia Biosciences's last earnings report?
- When does Arcadia Biosciences report earnings?
- Should I buy Arcadia Biosciences stock now?